United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-060_6b4c9ec2-308f-4b60-941c-34a2c7a7882c
- Product NDC
- 71205-060
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Naproxen
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160705
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-14) · 71205-060-14
- 15 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-15) · 71205-060-15
- 20 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-20) · 71205-060-20
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-30) · 71205-060-30
- 40 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-40) · 71205-060-40
- 45 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-45) · 71205-060-45
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-60) · 71205-060-60
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-90) · 71205-060-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →